166 related articles for article (PubMed ID: 1719257)
1. [Factor VIII epitopes recognized by inhibitors in hemophiliacs].
Hayashi T; Niiya K; Sakuragawa N; Ichihara K; Yamazaki T; Watanabe A
Rinsho Ketsueki; 1991 Sep; 32(9):945-50. PubMed ID: 1719257
[TBL] [Abstract][Full Text] [Related]
2. [Characterization of the factor VIII inhibitor in a patient with chronic renal failure].
Uemura Y; Niiya K; Takeuchi T; Miyoshi I
Rinsho Ketsueki; 1991 Jan; 32(1):39-42. PubMed ID: 1708430
[TBL] [Abstract][Full Text] [Related]
3. [Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII].
Shima M; Sawamoto Y; Kamisue M; Shibata Y; Tuzi S; Kuwabara M; Tanaka I; Tanizawa T; Tanaka A; Ueda M; Kakishita E; Yoshioka A
Rinsho Ketsueki; 1996 Nov; 37(11):1303-8. PubMed ID: 8960666
[TBL] [Abstract][Full Text] [Related]
4. [Acquired hemophilia caused by autoantibodies against factor VIII coagulation activity. Clinical, biological study and therapeutic indications. Experience based on a study of 9 cases].
Liozon E; Delaire L; Turlure P; Jaccard A; Loustaud-Ratti V; Réméniéras L; Julia A; Gaillard S; Bordessoule D; Vidal E
Ann Med Interne (Paris); 1997; 148(7):477-90. PubMed ID: 9538386
[TBL] [Abstract][Full Text] [Related]
5. [Suppression of factor VIII inhibitor in children with hemophilia A].
Zenz W; Muntean W
Padiatr Padol; 1987; 22(4):345-52. PubMed ID: 3125510
[TBL] [Abstract][Full Text] [Related]
6. Treatment of anti-factor VIII antibodies.
Blatt PM; White GC; McMillan CW; Roberts HR
Thromb Haemost; 1977 Aug; 38(2):514-23. PubMed ID: 579493
[TBL] [Abstract][Full Text] [Related]
7. [Immunoblotting analysis of acquired factor VIII inhibitor in an elderly man].
Kikuchi M; Sano M; Shimamoto Y; Yamaguchi M; Tadano J; Takahashi I; Kamiya T
Rinsho Ketsueki; 1993 Jul; 34(7):876-8. PubMed ID: 7689663
[TBL] [Abstract][Full Text] [Related]
8. Surgery for a chronic cystic hematoma on the right thigh in a hemophiliac A with a potent factor VIII inhibitor.
Masuhara K; Shimizu T; Kawasaki N; Fukui H; Sakai Y; Shima M; Mikami S; Yoshioka A
Nihon Seikeigeka Gakkai Zasshi; 1982 Dec; 56(12):1719-27. PubMed ID: 6820658
[TBL] [Abstract][Full Text] [Related]
9. A factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit factor VIII binding to von Willebrand factor and to phosphatidylserine.
Shima M; Scandella D; Yoshioka A; Nakai H; Tanaka I; Kamisue S; Terada S; Fukui H
Thromb Haemost; 1993 Mar; 69(3):240-6. PubMed ID: 7682339
[TBL] [Abstract][Full Text] [Related]
10. The effect of naturally occurring antibodies to factor VIII on an immunoradiometric assay for factor VIII coagulant antigen. Observation on a cross-reacting material-positive (CRM+) hemophiliac with a factor VIII inhibit.
Brown JE; Carton CL; Hougie C
J Lab Clin Med; 1981 Jan; 97(1):65-71. PubMed ID: 6778942
[TBL] [Abstract][Full Text] [Related]
11. [Acquired inhibitors (autoantibodies) to coagulation factors in non-hemophilic patients].
Okamura T; Tsuda H
Rinsho Ketsueki; 1993 May; 34(5):583-7. PubMed ID: 7686235
[TBL] [Abstract][Full Text] [Related]
12. [Immunosuppressive treatment of a spontaneous inhibitor hemophilia A using cyclophosphamide, vincristine and prednisone following prior Factor VIII stimulation].
Dürig J; de Wit M; Fiedler W; Marx G; Hossfeld DK
Schweiz Med Wochenschr; 1996 Nov; 126(47):2026-31. PubMed ID: 8984611
[TBL] [Abstract][Full Text] [Related]
13. Immunochemical characterization of factor VIII inhibitors.
Hoyer LW; Gawryl MS; de la Fuente B
Prog Clin Biol Res; 1984; 150():73-85. PubMed ID: 6431443
[TBL] [Abstract][Full Text] [Related]
14. Induction of human factor VIII inhibitors in rats by immunization with human recombinant factor VIII: a small animal model for humans with high responder inhibitor phenotype.
Jarvis MA; Levin LG; Harrison JA; DePianto DJ; Suzuki CM; Ziaja CL; Brown JE; Jolly KW; Reisner HM; Abildgaard CF; Powell JS
Thromb Haemost; 1996 Feb; 75(2):318-25. PubMed ID: 8815584
[TBL] [Abstract][Full Text] [Related]
15. [Transient inhibitors developed in two cases of hemophilia A].
Fujiwara F; Kanoh G; Ogawa H; Takaya K; Hibi S; Shima M; Yoshioka A; Imashuku S
Rinsho Ketsueki; 1997 Dec; 38(12):1263-8. PubMed ID: 9455145
[TBL] [Abstract][Full Text] [Related]
16. Epitope localization of monoclonal antibodies against factor VIII light chain which inhibit complex formation by factor VIII with von Willebrand factor.
Shima M; Yoshioka A; Nakai H; Tanaka I; Sawamoto Y; Kamisue S; Terada S; Fukui H
Int J Hematol; 1991 Dec; 54(6):515-22. PubMed ID: 1724391
[TBL] [Abstract][Full Text] [Related]
17. [Hemophiliacs with inhibitor. Experience at the Center of Medical Action for Hemophilia of the S. José Hospital].
Diniz MJ; Dias Francisco F; Tavares ML; Leal I
Acta Med Port; 1992 Apr; 5(4):178-80. PubMed ID: 1605065
[TBL] [Abstract][Full Text] [Related]
18. [Development of factor VIII inhibitor in three non-hemophiliac patients].
Kiguchi T; Niiya K; Yamawaki Y; Shima M; Harada M
Rinsho Ketsueki; 2000 Nov; 41(11):1195-200. PubMed ID: 11193439
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A.
Sawecka J; Skulimowska J; Windyga J; Lopaciuk S; Kościelak J
Arch Immunol Ther Exp (Warsz); 2005; 53(4):352-6. PubMed ID: 16088320
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of patients with hemophilia A having antibodies to factor VIII].
Lopaciuk S; Ziemski JM
Acta Haematol Pol; 1979; 10(2):115-22. PubMed ID: 474044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
